Here, we show lower levels of miR-142 in CD34+CD38− blasts from BC CML patients than in those from CP CML patients, suggesting that miR-142 deficit is implicated in BC evolution. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.